Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL. Sas TC, et al. Among authors: waelkens jj. Arch Dis Child. 1999 Jan;80(1):36-41. doi: 10.1136/adc.80.1.36. Arch Dis Child. 1999. PMID: 10325756 Free PMC article. Clinical Trial.
Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A, de Muinck Keizer-Schrama S, Stijnen T, Waelkens J, Wit JM, Vulsma T, Gerver WJ, Reeser H, Delemarre-van de Waal H, Jansen M, Drop S. van Teunenbroek A, et al. Clin Endocrinol (Oxf). 1997 Apr;46(4):451-9. doi: 10.1046/j.1365-2265.1997.1610972.x. Clin Endocrinol (Oxf). 1997. PMID: 9196608 Clinical Trial.
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. Menke LA, et al. Among authors: waelkens jj. J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8. J Clin Endocrinol Metab. 2010. PMID: 20061421 Clinical Trial.
A controlled trial of methionyl growth hormone therapy in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
Wit JM, Rietveld DH, Drop SL, Oostdijk W, Gons M, Otten BJ, Delemarre-van de Waal HA, Reeser M, Waelkens JJ, Bot A. Wit JM, et al. Among authors: waelkens jj. Acta Paediatr Scand. 1989 May;78(3):426-35. doi: 10.1111/j.1651-2227.1989.tb11103.x. Acta Paediatr Scand. 1989. PMID: 2662700 Clinical Trial.
Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
Wit JM, Fokker MH, de Muinck Keizer-Schrama SM, Oostdijk W, Gons M, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ. Wit JM, et al. Among authors: waelkens jj. J Pediatr. 1989 Nov;115(5 Pt 1):720-5. doi: 10.1016/s0022-3476(89)80648-1. J Pediatr. 1989. PMID: 2809902 Clinical Trial.
54 results